| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |